Caladrius Biosciences Inc. (CLBS) dropped -5.67% or -0.35 to $5.82. It is near to 102421 shares traded, which is 15.84% compare to the average total volume 646427. The market cap of CLBS is $55.70 million. The year to date change is 61.08%. The 52 week price range is from $2.63 to $11.65. Price of CLBS have changed -20.14% during last week. It have changed 68.29% over last month, 20.63% over last 3 months, 101.75% over last 6 months and 42.86% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLBS is 4.49. It is -22.85% below current price. The 200-day Moving Averages for CLBS is 4.16. It is -28.52% below current price. The 52-week High is 11.65. It is 100.17% from the current price. The 52-week Low is 2.63. It is -54.81% from current price.
There are some statistics of CLBS. It is has market cap $55.70 million. The share outstanding is 9.57 million. The average volume is 646427. It has 118.82M cash and 961196 in debt. The percent of top 15 Institution holding is 5.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLBS is 122.13%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLBS is 51.99%.